Gnca stock predictions

Apr 03, 2020 · Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures.

Penny Stocks Post Tag - GNCA - Penny Stocks to Buy, Picks ... Penny Stocks ( is the top online destination for all things Micro-Cap Stocks. On you will find a comprehensive list of Penny Stocks & discover the best Penny Stocks to buy, top penny stock news and micro-cap stock articles. … GNMX Stock Price, Forecast & News (Aevi Genomic Medicine) Exploring Aevi Genomic Medicine (NASDAQ:GNMX) stock? View GNMX's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat.

6 Jul 2018 Market Cap ($M), 45.89. Enterprise Value ($M), 10.76. Book Value ($M), 31.37. Book Value / Share, 1.20. Price / Book, 1.38. NCAV ($M), 20.01.

Owner, 4,186,243. GNCA / Genocea Biosciences, 10% Owner, 7,225,676 Does this Insider's Trades Predict Future Stock Performance? The following charts  25 Feb 2020 In any case, if GNCA is on your penny stocks watch list, 2/27 could be a date Based on the current trading price of the penny stock, it could be  6 Jul 2018 Market Cap ($M), 45.89. Enterprise Value ($M), 10.76. Book Value ($M), 31.37. Book Value / Share, 1.20. Price / Book, 1.38. NCAV ($M), 20.01. 15 Nov 2019 SVB Leerink launched coverage of Genocea Biosciences (NASDAQ:GNCA) with an “outperform” rating and price target of $7. The stock closed 

How Genocea Biosciences Inc (GNCA) Stacks Up Against Its Peers Published on December 17, 2016 at 4:14 pm by Ghia Malicay in News Share Tweet Share Email

Analyst Coverage — Stock Information — Investor Relations ... As of April 02, 2020 Genocea Biosciences is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Genocea Biosciences's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of …

Genocea Biosciences Inc (NASDAQ:GNCA), a company developing T cell-directed immunotherapies and vaccines, is down by 27% after the company’s universal vaccine candidate against pneumococcus, GEN

5 Mar 2020 Based on the latest results, analysts are suggesting that the target price for GNCA stock should be $1.94 per share in the course of the next 12 

Indo Global Exchange(s) Pte., Ltd. (IGEX) Stock Message ...

60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. NUGL | NUGL Inc. Stock Price & News - WSJ

SDPI Stock Price | Superior Drilling Products Inc. Stock ... SDPI | Complete Superior Drilling Products Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.